Portfolio company
Ryme Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
The company develops catheter-based therapies for patients with chronic obstructive pulmonary disease to improve airflow and reduce symptoms through targeted lung denervation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Aetherus
Aetherus develops a handheld, non-invasive breathing device providing rapid relief from breathlessness for patients suffering from chronic obstructive pulmonary disease.
BPCOmedia
This company develops a remote monitoring platform using artificial intelligence to predict and prevent respiratory exacerbations for patients with chronic obstructive pulmonary disease.
AirNexis
This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.
Aerin Medical
This company develops non-invasive radiofrequency devices for ear, nose and throat physicians to treat patients with nasal airway obstruction and chronic rhinitis.
Elevation Pharmaceuticals
This biopharmaceutical company develops inhaled aerosol therapies for patients with chronic obstructive pulmonary disease to improve lung function and reduce treatment burden.
Kither Biotech
This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.
Aer Therapeutics
This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.
